Concentrations of proinsulin like molecules predict coronary heart disease risk independently of insulin: Prospective data from the Caerphilly Study

Diabetologia

Volumn 45, Issue 3, 2002, Pages 327-336

  Yudkin, J S ^a   May, M ^b   Elwood, P ^c   Yarnell, J W G ^c   Greenwood, R ^b   Davey Smith, G ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

Coronary heart disease; Des 31, 32 proinsulin; Insulin; Plasminogen activator inhibitor; Proinsulin

Indexed keywords

ANTIGEN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROINSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL STUDY; CLINICAL TRIAL; DIASTOLIC BLOOD PRESSURE; HUMAN; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; CORONARY DISEASE; HUMANS; INSULIN; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROINSULIN; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0036203254     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-001-0756-7     Document Type: Article

References (54)

1. The effect of insulin on renal sodium metabolism. A review with clinical implications
2. Diet, obesity and hypertension; an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis
3. Effect of differences in glucose tolerance on insulin's ability to regulate carbohydrate and free fatty acid metabolism in obese individuals
4. Role of insulin resistance in human disease
5. Insulin and atheroma. 20 Year perspective
6. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: Results from two population studies in Finland
7. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population
8. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations
9. Hyperinsulinemia as an independent risk factor for ischemic heart disease
10. Insulin in ischaemic heart disease: Are associations mediated by triglyceride levels? The Caerphilly prospective study
11. Insulin and risk of cardiovascular disease: A meta-analysis
12. Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics
13. Intact proinsulin, des 31, 32 proinsulin, and specific insulin concentrations among nondiabetic and diabetic subjects in populations at varying risk of type 2 diabetes
14. Circulating proinsulin-like molecules
15. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes
16. Insulin deficiency in non-insulin-dependent diabetes
17. The relationship of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in Type II (non-insulin dependent) diabetic subjects
18. Association of proinsulin-like molecules with lipids and fibrinogen in non-diabetic subjects - Evidence against a modulating role for insulin
19. Relationship of proinsulin and insulin to cardiovascular risk factors in non-diabetic subjects
20. The relationship of concentrations of insulin and proinsulin-like molecules with coronary heart disease prevalence and incidence. A study of two ethnic groups
21. Thinness at birth and insulin resistance in adult life
22. Glucose tolerance and resistance to insulin-stimulated glucose uptake in men aged 70 years in relation to size at birth
23. Type II (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): Relation to reduced fetal growth
24. Birth weight and the insulin resistance syndrome: Association of low birth weight with truncal obesity and raised plasminogen activator inhibitor-1 but not with abdominal obesity or plasma lipid disturbances
25. Raised proinsulin as an early indicator of β-cell dysfunction
26. Fibrinogen, viscosity and white blood cell count are major risk factors for ischemic heart disease
27. Cardiovascular survey methods
28. Birthweight, adult risk factors and incident coronary heart disease: The Caerphilly study
29. Birthweight, body-mass index in middle age, and incident coronary heart disease
30. Does non-diabetic hyperglycaemia predict future IHD? Evidence from the Caerphilly and Speedwell Studies
31. Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly study
32. Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulin
33. Understanding oral glucose tolerance: Comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion
34. The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly-diagnosed Type II diabetes: The Insulin Resistance Atherosclerosis study
35. Insulin resistance does not change the ratio of proinsulin to insulin in normal volunteers
36. The relation of proinsulin, insulin, and proinsulin-to-insulin ratio to insulin sensitivity and acute insulin response in normoglycemic subjects
37. Insulin propeptides in conditions associated with insulin resistance in humans and their relevance to insulin measurements
38. Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes
39. Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome
40. Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS)
41. The effects of biosynthetic human proinsulin on carbohydrate metabolism in non-insulin-dependent diabetes mellitus
42. Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycaemic control
43. Effect of insulin versus sulfonylurea therapy on cardiovascular risk factors and fibrinolysis in type II diabetes
44. Are insulin and proinsulin independent risk markers for premature coronary artery disease?
45. Relationship of proinsulin and insulin with non-insulin dependent diabetes mellitus and coronary heart disease in Japanese-American men: Impact of obesity - Clinical research centre study
46. Insulin, intact and split proinsulin, and coronary artery disease in young men
47. High proinsulin concentration precedes acute myocardial infarction in a nondiabetic population
48. How good a marker is insulin level for insulin resistance?
49. Poor agreement between self-reported birth weight and birth weight from original records in adult women
50. Type II (non-insulin-dependent) diabetes mellitus: The thrifty phenotype hypothesis
51. C-reactive protein in healthy subjects: Association with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue?
52. High affinity binding sites for proinsulin in human IM-9 lymphoblasts
53. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)